The presence of genes encoding different types of ␤-lactamases (TEM, SHV, OXA-1, CMY, CTX-M, FOX, and the mutation in the promoter of ampC) in the five isolates was studied. The detection of the bla TEM , bla SHV , and bla OXA-1 genes was carried out by PCR ( Table 2 ). The bla TEM and bla SHV amplicons obtained were sequenced (both strands) using the same set of primers as for the PCRs. The DNA and the deduced amino acid sequences were compared with those previously described (GenBank database and G. Jacoby and K. Bush website [http://www.lahey.org/studies/webt.htm]). The nomenclature used for the bla TEM variants and promoters was as previously proposed (13, 15) .
The detection of plasmidic class C ␤-lactamases was carried out using specific primers for the amplification of bla CMY and bla FOX genes ( Table 2 ). The complete sequence (approximately 1,800 bp) of the amplified fragment obtained with bla CMY primers was determined on both strands by applying a primerwalking strategy to obtain the whole bla CMY sequence as well as the upstream and downstream regions. The detection of plasmidic CTX-M-9-type and CTX-M-10-type (class A ␤-lactamases) was also analyzed by PCR and by subsequently sequencing the amplicons (Table 2 ). Positive and negative controls were used in all reactions.
A positive bla TEM PCR result was obtained for three of the five E. coli isolates, and a positive bla SHV PCR result was obtained for an additional isolate (Table 3) . Each of the three bla TEM amplicons was identified as a bla TEM-1b gene (the weak P3 promoter was identified in two of the isolates). The bla SHV amplicon was identified as a bla SHV-12 gene and was obtained in an E. coli isolate with an antibiotic resistance phenotype typical of an ESBL. The SHV-12 ␤-lactamase had been previously found in human (19, 28) and animal E. coli clinical isolates (Teshager et al., letter, 2000) but never in healthy animal isolates.
A ␤-lactamase CMY-2 was found in one E. coli isolate under study that also harbored a bla TEM-1b gene ( Table 3 ). The sequence of the 1,800-bp amplicon, which included the bla CMY-2 gene, showed a genetic organization that enclosed (7) in two E. coli isolates from sick animals (a chicken and a pig) which harbored the bla CMY-2 gene. The CMY-2 ␤-lactamase has been previously detected in clinical bovine and porcine E. coli isolates (27) but never in healthy animals.
The only isolate (E. coli AOEC429432) for which cefotaxime had a MIC (128 g/ml) higher than that of ceftazidime (0.5 g/ml) gave a positive PCR result with the primers to detect bla CTX-M-9 -like genes. This product was sequenced, and the deduced amino acid sequence revealed a CTX-M-14 ␤-lactamase. This isolate also harbored a bla TEM-1b gene ( Table 1) . The nucleotide sequence of a 162-bp region upstream of the bla CTX-M-14 gene in this isolate was determined and analyzed with the BLASTN program at the National Center for Biotechnology Information. The sequence was 100% identical to the upstream region of the bla CTX-M-9 gene that was included in the In60 integron (23) (GenBank accession no. AF74129). Furthermore, our sequence included the 28-bp segment that had been proposed as a recognition site for the orf513 putative transposase (1). These results suggested that the bla CTX-M-14 gene in our isolate was located in an integron, as had been reported for other CTX-M ␤-lactamases (1, 23) . The CTX-M-14 ␤-lactamase had been previously detected in human clin- (4, 11, 16, 20, 24) but never before in animal isolates. Negative results were obtained for the five E. coli isolates analyzed when the CTX-M-10-like, FOX, and OXA-1 sets of primers were used in the PCR assay.
The regulatory region of the chromosomal ampC gene was amplified by PCR (Table 2 ) with the five isolates and sequenced. The mutations in the promoter and attenuator region were studied by comparing the sequence with the same region in the E. coli K-12 ampC gene (14) . No mutations were found in the two E. coli isolates which harbored the CMY-2 or CTX-M-14 ␤-lactamases. Mutations at positions Ϫ18, Ϫ1, and ϩ58 were detected in the E. coli isolate with the bla SHV-12 gene. Nevertheless, mutations at positions Ϫ42, Ϫ18, Ϫ1, and ϩ58 were detected in the other two isolates (Table 1 ). Mutations at the Ϫ42 position were associated with hyperproduction of the chromosomal AmpC ␤-lactamase and caused resistance to cefoxitin and a diminished susceptibility to extended-spectrum cephalosporins, as has been previously reported (9) . The E. coli isolates which harbored bla CMY-2 , bla CTX-M-14 , or bla SHV-12 genes did not show a mutation at Ϫ42 position (Table 3) .
To our knowledge, this is the first time that genes encoding SHV-12, CMY-2, and CTX-M-14 ␤-lactamases have been detected in E. coli isolates from healthy animals. The use of extended-spectrum cephalosporins in chickens is very unusual, and the possibility of cross-selection with other antimicrobials used in poultry (such as sulfonamides and tetracyclines, among others) might explain this discovery and should be further analyzed in the future.
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